Physician

Charles A Buzzanell, M.D.

According to 2025 Medicare claims, Charles Buzzanell, M.D. (NPI: 1841364551) practices interventional pain management (ipm) in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is BLUE RIDGE PAIN MANAGEMENT & PALLIATIVE CARE PA (NPI: 1578618591; TIN: 562114489) and primary practice location at 28803-8587.

Buzzanell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 321 traditional Medicare patients, billed 5,486 HCPCS/CPT codes, and received $320,942 in Medicare payments. The top billing code was 27096 (Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance). Part D data shows 5,055 prescription claims across 518 beneficiaries totaling $557,988 in drug costs, led by Relistor (Methylnaltrexone Bromide). 2021 DME data shows 26 claims. Open Payments data shows 62 records totaling $1,739. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $354,975 and ending at $320,942. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $231,961 and ending at $557,988. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,619 to $1,440.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	245	7,954	$354,975
2016	279	6,739	$322,004
2017	337	8,708	$484,669
2018	327	8,233	$436,717
2019	408	8,192	$523,654
2020	379	5,224	$360,349
2021	408	6,384	$455,283
2022	344	5,371	$349,349
2023	358	5,759	$384,649
2024	321	5,486	$320,942

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	1,609	$231,961
2016	154	975	$131,529
2017	232	1,305	$190,928
2018	267	1,613	$200,101
2019	271	1,178	$121,336
2020	172	702	$57,208
2021	270	1,175	$74,315
2022	261	964	$90,544
2023	443	2,746	$267,076
2024	518	5,055	$557,988

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	20	$1,341
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$749
2019	N/R	25	$1,465
2020	N/R	14	$724
2021	N/R	26	$1,361
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	102	156	$160
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	107	198	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	292	1,286	$59
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	225	593	$40
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	204	1,894	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Relistor	Methylnaltrexone Bromide	33	1,170	$95,996
Xtampza Er	Oxycodone Myristate	109	3,165	$72,490
Oxycontin	Oxycodone Hcl	62	1,825	$44,454
Ubrelvy	Ubrogepant	22	730	$38,081
Qulipta	Atogepant	22	780	$29,542

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,739	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles A. Buzzanell, M.D.?

Tedicare shows public-source Medicare data for Charles A. Buzzanell, M.D. (NPI 1841364551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles A. Buzzanell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles A. Buzzanell, M.D.?

Charles A. Buzzanell, M.D. is linked to BLUE RIDGE PAIN MANAGEMENT & PALLIATIVE CARE PA (billing NPI 1578618591) in the available physician profile data.

Does Charles A. Buzzanell, M.D. have Open Payments data?

Charles A. Buzzanell, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.